“HOT” stock: Regis Healthcare (REG)
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why Regis Healthcare (REG) is currently a buying opportunity.
Independent. Trusted. Proven.
Investment analysis, share recommendations, and market insights.
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why Regis Healthcare (REG) is currently a buying opportunity.
I’ve been looking for recommendations for two of my financial planning clients. I’ll share with you what I’ve come up with. Be clear on this: if they were full-on growth investors, then I’d be more aggressive.
In a very volatile April, our model portfolios finished higher. Our income portfolio continues to outperform.
In our “HOT” stock column today, Raymond Chan, Head of Asian Desk at Morgans, explains that Morgans sees Iress Limited (IRE) providing investors a decent upside ‘option’.
Here’s a look at four ASX companies that say they’re global leaders, and are hoping to be the next WiseTech, replicating what it has done in the global logistics industry.
The big miners have fallen too far, and I see reasonable value for the first time in a long time. Prospective investors can buy stocks directly (and I’ll tell you my preferences), though as you’d expect, I do like resource-sector ETFs for more diversified exposure.
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, says Boss Energy (BOE) is a stock he likes because over the next several years the amount of uranium supply coming online isn’t enough to meet current demand.
The investments I talked about today are linked to what I think are believable future scenarios. All of them have terrific upside potential, but you just might have to be patient with a few of them.
While Bendigo has struggled in recent times, last week it announced its results for the first half and the stock rallied 13% on the announcement. Has it turned the corner? Let’s take a closer look…
Raymond Chan, Head of Asian Desk at Morgans, is again a fan of Resmed (RMD). In our “HOT STOCK” column today, Raymond goes through the reasons why he continues to believe RMD is an ADD to an investor’s portfolio.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.